Synonym |
3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 |
Species |
Human |
Protein Accession |
P12345 |
Purity |
≥ 95% |
Endotoxin Level |
< 1.0 EU per µg |
Biological Activity |
Not determined |
Expression System |
E. coli |
Fusion Tag |
None |
Predicted Molecular Mass |
10 kDa |
Formulation |
Lyophilized from a 0.2 μm filtered solution in PBS |
Reconstitution |
Centrifuge vial before opening. Reconstitute in sterile ddH2O to a concentration ≥ 100 µg/ml
|
Storage & Stability |
Store at -80°C. Avoid repeated freeze-thaw cycles. |
FAQ
What is 3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2, and what are its primary
uses?
3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 is a complex peptide compound that often
garners interest due to its potential applications in biochemical and pharmacological research.
Researchers are exploring this compound largely for its unique structure, which allows it to interact
with certain proteins and enzymes in a manner that could be beneficial for understanding various
biological processes. In particular, peptides like 3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 can
mimic or inhibit natural peptide functions in the human body, making them subjects of study for
therapeutic applications. For example, understanding how this peptide interacts with certain receptors
might provide insights into developing new treatments for conditions where natural peptides are
dysfunctional. The thioether group introduced by the mercaptopropionyl moiety might endow this compound
with distinctive binding properties that make it more or less effective in mimicking natural processes.
This characteristic may also provide a protective effect against enzymatic degradation, granting the
molecule more stability in biological environments and potentially increasing its efficacy as a
therapeutic tool. Another fascinating area of research is its capacity for targeted delivery or as a
component of a more complex drug delivery system designed to reach specific tissues or cells while
bypassing others. This aspect could revolutionize treatments for diseases that require precise
targeting, such as certain types of cancer, by minimizing off-target effects and thereby reducing side
effects. Researchers are continually exploring these potentialities to harness the full capabilities of
such peptides in various fields of medicine and biochemistry.
Can you explain the structural
uniqueness of 3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2?
The structural uniqueness of
3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 lies in its intricate arrangement involving both specific
amino acid sequences and distinctive chemical groups that define its chemical behavior and interactions.
This peptide sequence is built around a combination of natural and synthetic amino acids that confer
particular structural properties. The presence of 3-Mercaptopropionyl is one of the defining features,
as it integrates a sulfur atom within the backbone, creating a potential site for forming disulfide
bonds or engaging in thiol-based chemistry. This characteristic may enable the molecule to engage in
specific and stable interactions that non-sulfur-containing peptides might not achieve. Such features
might render the peptide more resistant to enzymatic breakdown, thus making it more suitable for in vivo
applications where stability is often a critical issue. Moreover, the inclusion of a p-chloro-D-Phe
(p-chloro-D-phenylalanine) grants the peptide unique binding affinities. The halogenation of
phenylalanine introduces additional hydrophobic properties and may alter the molecule’s overall
topography, which can influence its affinity and specificity for certain biological targets. This
halogenated site may engage in various non-covalent interactions such as pi-pi stacking or halogen
bonding with target biological molecules, enhancing its ability to modulate biological activity. This
specific combination of sulfur-containing groups and halogenated aromatic rings uniquely equips this
peptide to participate in complex molecular interactions, opening possibilities for fine-tuning drug
binding properties or altering molecular interaction pathways. Such structural nuances underscore its
potential in drug design and therapeutic applications, wherein each component plays a deliberate role in
modulating targeted activities within a biological environment.
How does the peptide's
composition affect its biochemical interactions?
The composition of
3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 significantly affects its biochemical interactions,
predominantly by dictating its affinity, specificity, and stability in varying biochemical environments.
The sequence of amino acids in a peptide determines how it folds and what particular structure it
adopts, which in turn affects its biological activity. This peptide is specifically constructed to
include both typical peptidic structures and atypical constituents. The presence of 3-Mercaptopropionyl
is notable for introducing a reactive thiol group. Thiol groups are known for their ability to form
disulfide bridges, which can drastically affect the peptide's conformation and stability. In biological
systems, these thiol groups could form reversible disulfide bonds with other cysteine residues,
potentially regulating biological activity through redox mechanisms. Additionally, the potential for
disulfide bonding can aid in the peptide's ability to stabilize the structure of proteins or to tether
the peptide to other molecules, such as on the surface of gold nanoparticles, for biotechnological
applications. Further, the p-chloro-D-Phe portion of the molecule serves multiple roles. The presence of
a chlorine atom adds a degree of electron-withdrawing power and increases the lipophilicity of the
molecule, enhancing its ability to pass through lipid membranes and potentially increasing its
bioavailability. Its chirality as a D-enantiomer also prevents degradation by standard proteolytic
enzymes that recognize L-amino acids, giving it a significant advantage in terms of stability in vivo.
These properties enable it to interact with a broader range of targets with increased specificity and
less off-target activity, potentially leading to fewer side effects. The specific sequence and structure
of 3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 profoundly shape its biochemical interactions and
functionality, giving it potential therapeutic value.
What makes peptides like
3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 attractive for drug development?
Peptides such as
3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 are increasingly attractive for drug development due to
their remarkable specificity, adaptability, and intrinsic biological activity. Peptides inherently
possess a high degree of specificity for their biological targets because they can mimic natural ligands
more closely than small molecules typically can. This specificity translates into fewer side effects
compared to standard small-molecule drugs, as peptides are less likely to interact with off-target
proteins. Their construction from amino acids also provides a safer profile in terms of toxicity, since
they tend to be broken down into non-harmful amino acids and peptide fragments as opposed to potentially
toxic metabolites. Moreover, the capacity of peptides to penetrate cell membranes and interact with
intracellular targets opens new therapeutic avenues that traditional drugs may not access as
effectively. The design flexibility of peptides allows researchers to modify their structures,
incorporating natural or non-natural amino acids to enhance their properties for therapeutic use. For
instance, changing the structure of these peptides to include modified amino acids like p-chloro-D-Phe
can improve their stability, decrease degradation, and increase membrane permeability. This adaptability
aids in overcoming common hurdles in drug development, such as rapid clearance from the body and short
half-life, as well as enhancing peptides' pharmacokinetic profiles. The rise in solid-phase peptide
synthesis technologies makes production more feasible at scale, further promoting the integration of
peptides in drug development pipelines. In addition, with advances in recombinant DNA technology, it is
becoming increasingly feasible to produce these peptides biologically, which can reduce the cost and
complexity of production. Furthermore, the ability to conjugate peptides with other molecules, such as
polyethylene glycol (PEG) or nanoparticles, enhances their delivery and efficacy, making them extremely
versatile. Therefore, peptides like 3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 serve as compelling
candidates in drug development, offering the potential to address challenging therapeutic targets with
precision and potency.
How stable is 3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 under various
conditions, and what factors influence its stability?
The stability of
3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 is largely influenced by its unique chemical composition
and the environment in which it is placed. One of the crucial aspects affecting its stability is the
peptide backbone and the side chains' resistance to enzymatic degradation. The presence of D-amino
acids, such as p-chloro-D-Phe, imparts a degree of stability by preventing rapid breakdown by
proteolytic enzymes that typically target L-amino acids. This chirality makes it a less recognizable
substrate for these enzymes, allowing the peptide to maintain its structural integrity for a more
extended period when administered to biological systems. Additionally, the structural design that
includes a 3-Mercaptopropionyl group may contribute to maintaining the stability of the peptide through
the formation of disulfide bonds, enabling the peptide to withstand harsh conditions and extending its
half-life. The external conditions, including temperature, pH, solvents, and ionic strength, can also
play significant roles in determining the stability of the peptide. Harsh pH levels can alter amino acid
ionization states, potentially disrupting the structural conformation, though the incorporation of
atypical amino acids can mitigate some of these effects. While elevated temperatures can increase the
rate of peptide degradation, the unique backbone and stabilization from the mercapto group may
contribute to its resistance against thermal denaturation to some extent. Improved formulation
strategies, such as utilizing specific buffers or integrating stabilizing agents, can also enhance the
peptide’s stability in various conditions, helping to maintain its therapeutic efficacy. Encapsulation
within nanoparticles or microemulsions can further shield the peptide from environmental degradation.
Thus, while the stability of 3-Mercaptopropionyl-YdWKYC-p-chloro-D-Phe-NH2 may be challenged by extreme
conditions, its unique design offers an inherent robustness that allows it to remain functionally stable
across a range of conditions, making it a promising candidate for further exploration in therapeutic
developments.